Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Crawley

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Pancreas|March 27, 2003
Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasiaHee-Ug Park, Jong-Woo Kim, Grace E Kim, et al.
Leukemia|July 30, 2003
Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfaD Marin, S Marktel, M Bua, et al.
Plos One|March 17, 2011
High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888Susan K Lyman, Suzanne C Crawley, Ruoyu Gong, et al.
The Journal of Biological Chemistry|June 22, 2002
Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-kappa BHae-Wan Lee, Dae-Ho Ahn, Suzanne C Crawley, et al.
The Journal of Clinical Investigation|April 15, 1996
Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndromeA C Crawley, D A Brooks, V J Muller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.
Bone Marrow Transplantation|February 26, 2014
Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHDF L Dignan, S Aguilar, J J Scarisbrick, et al.
Bone Marrow Transplantation|June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMTS P Robinson, C Canals, J J Luang, et al.
Bone Marrow Transplantation|September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working partyC Scheid, L de Wreede, A van Biezen, et al.
Bone Marrow Transplantation|May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working PartyL Bento, A Boumendil, H Finel, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Pancreas|March 27, 2003
Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasiaHee-Ug Park, Jong-Woo Kim, Grace E Kim, et al.
Leukemia|July 30, 2003
Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfaD Marin, S Marktel, M Bua, et al.
Plos One|March 17, 2011
High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888Susan K Lyman, Suzanne C Crawley, Ruoyu Gong, et al.
The Journal of Biological Chemistry|June 22, 2002
Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-kappa BHae-Wan Lee, Dae-Ho Ahn, Suzanne C Crawley, et al.
The Journal of Clinical Investigation|April 15, 1996
Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndromeA C Crawley, D A Brooks, V J Muller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.
Bone Marrow Transplantation|February 26, 2014
Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHDF L Dignan, S Aguilar, J J Scarisbrick, et al.
Bone Marrow Transplantation|June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMTS P Robinson, C Canals, J J Luang, et al.
Bone Marrow Transplantation|September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working partyC Scheid, L de Wreede, A van Biezen, et al.
Bone Marrow Transplantation|May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working PartyL Bento, A Boumendil, H Finel, et al.
Pageof 13